Detection of severity in Alzheimer's disease (AD) using computational modeling
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyunjo | - |
dc.date.available | 2020-02-27T15:43:42Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2018-05 | - |
dc.identifier.issn | 0973-8894 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5279 | - |
dc.description.abstract | The prevalent cause of dementia - Alzheimer's disease (AD) is characterized by an early cholinergic deficit that is in part responsible for the cognitive deficits (especially memory and attention defects). Prolonged AD leads to moderate-to-severe AD, which is one of the leading causes of death. Placebo-controlled, randomized clinical trials have shown significant effects of Acetyl cholin esterase inhibitors (ChEIs) on function, cognition, activities of daily living (ADL) and behavioral symptoms in patients. Studies have shown comparable effects for ChEIs in patients with moderate-to-severe or mild AD. Setting a fixed measurement (e.g. a Mini-Mental State Examination score, as a 'when to stop treatment limit) for the disease is not clinically rational. Detection of changed regional cerebral blood flow in mild cognitive impairment and early AD by perfusion-weighted magnetic resonance imaging has been a challenge. The utility of perfusion-weighted magnetic resonance imaging (PW-MRI) for detecting changes in regional cerebral blood flow (rCBF) in patients with mild cognitive impairment (MCI) and early AD was evaluated. We describe a computer aided prediction model to determine the severity of AD using known data in literature. We designed an automated system for the determination of AD severity. It is used to predict the clinical cases and conditions with disagreements from specialist. The model described is useful in clinical practice to validate diagnosis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BIOMEDICAL INFORMATICS | - |
dc.relation.isPartOf | BIOINFORMATION | - |
dc.title | Detection of severity in Alzheimer's disease (AD) using computational modeling | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000449668000013 | - |
dc.identifier.doi | 10.6026/97320630014259 | - |
dc.identifier.bibliographicCitation | BIOINFORMATION, v.14, no.5, pp.259 - 264 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 264 | - |
dc.citation.startPage | 259 | - |
dc.citation.title | BIOINFORMATION | - |
dc.citation.volume | 14 | - |
dc.citation.number | 5 | - |
dc.contributor.affiliatedAuthor | Kim, Hyunjo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | mini mental state examination | - |
dc.subject.keywordAuthor | acetyl cholin esterase inhibitors | - |
dc.subject.keywordAuthor | MRI | - |
dc.subject.keywordAuthor | K-means: algorithm simulation | - |
dc.subject.keywordPlus | ARTERIAL INPUT FUNCTION | - |
dc.subject.keywordPlus | MILD COGNITIVE IMPAIRMENT | - |
dc.subject.keywordPlus | SINGULAR-VALUE DECOMPOSITION | - |
dc.subject.keywordPlus | CEREBRAL-BLOOD-FLOW | - |
dc.subject.keywordPlus | AUTOMATIC SELECTION | - |
dc.subject.keywordPlus | BOLUS TRACKING | - |
dc.subject.keywordPlus | VOLUME | - |
dc.subject.keywordPlus | QUANTIFICATION | - |
dc.subject.keywordPlus | DEMENTIA | - |
dc.subject.keywordPlus | BRAIN | - |
dc.relation.journalResearchArea | Mathematical & Computational Biology | - |
dc.relation.journalWebOfScienceCategory | Mathematical & Computational Biology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.